P41EB032840
Project Grant
Overview
Grant Description
The National Center for Interventional Biophotonic Technologies (NCIBT) - Project Summary – Overall
The long-term goal of the National Center for Interventional Biophotonic Technologies (NCIBT) is to promote public health by advancing a new paradigm for intraprocedural, image-guided decision making. The center's strategy is to advance optical spectroscopy and imaging technologies, develop means of providing imaging results to medical practitioners at the time, in the form, and within the context they will be most useful in guiding decisions, and to maximize the impact of this work by involving as many scientists and physicians as possible in developing and using these technologies.
Initially, the center will promote technological advancements of interventional fluorescence lifetime imaging (IFLIM) and interferometric diffuse optical spectroscopy (IDOS) and their translation into clinical use. An open-ended intraprocedural platform will incorporate them and, eventually, complementary optical imaging technologies.
Specifically, NCIBT will:
1. Advance scalable optical imaging technology, built from the perspective of intelligent optical system design, to characterize tissue properties in the most effective manner.
2. Develop an intraprocedural platform that physically incorporates these technologies and integrates the resulting imaging data, details of the procedure, and patient-specific information within AI-based decision algorithms that guide, in real-time, therapeutic decisions.
3. Disseminate these technological advancements to research institutions and medical centers.
The significance of this project derives from its potential for rapid advancement, catalyzed by an AI-directed holistic approach to instrument design, of its optical imaging technologies and platform and their relevance to managing humanity's most common afflictions - cancer, stroke, heart disease, trauma, infection, and degenerative diseases.
NCIBT will ensure the national impact of these technological advancements by creating and expanding a network of collaborative research and service projects broadly distributed nationwide and implementing a comprehensive training and dissemination program. Annual workshops, hands-on training sessions at national meetings, in special courses and at UC Davis, presentations, and publications will educate, train, equip, and diversify potential users of NCIBT technology.
Bridging gaps between engineering and medicine and between technology development and clinical application will ensure that the needed technologies are developed and applied clinically to improve the nation's health.
The long-term goal of the National Center for Interventional Biophotonic Technologies (NCIBT) is to promote public health by advancing a new paradigm for intraprocedural, image-guided decision making. The center's strategy is to advance optical spectroscopy and imaging technologies, develop means of providing imaging results to medical practitioners at the time, in the form, and within the context they will be most useful in guiding decisions, and to maximize the impact of this work by involving as many scientists and physicians as possible in developing and using these technologies.
Initially, the center will promote technological advancements of interventional fluorescence lifetime imaging (IFLIM) and interferometric diffuse optical spectroscopy (IDOS) and their translation into clinical use. An open-ended intraprocedural platform will incorporate them and, eventually, complementary optical imaging technologies.
Specifically, NCIBT will:
1. Advance scalable optical imaging technology, built from the perspective of intelligent optical system design, to characterize tissue properties in the most effective manner.
2. Develop an intraprocedural platform that physically incorporates these technologies and integrates the resulting imaging data, details of the procedure, and patient-specific information within AI-based decision algorithms that guide, in real-time, therapeutic decisions.
3. Disseminate these technological advancements to research institutions and medical centers.
The significance of this project derives from its potential for rapid advancement, catalyzed by an AI-directed holistic approach to instrument design, of its optical imaging technologies and platform and their relevance to managing humanity's most common afflictions - cancer, stroke, heart disease, trauma, infection, and degenerative diseases.
NCIBT will ensure the national impact of these technological advancements by creating and expanding a network of collaborative research and service projects broadly distributed nationwide and implementing a comprehensive training and dissemination program. Annual workshops, hands-on training sessions at national meetings, in special courses and at UC Davis, presentations, and publications will educate, train, equip, and diversify potential users of NCIBT technology.
Bridging gaps between engineering and medicine and between technology development and clinical application will ensure that the needed technologies are developed and applied clinically to improve the nation's health.
Awardee
Funding Goals
TO SUPPORT HYPOTHESIS-, DESIGN-, TECHNOLOGY-, OR DEVICE-DRIVEN RESEARCH RELATED TO THE DISCOVERY, DESIGN, DEVELOPMENT, VALIDATION, AND APPLICATION OF TECHNOLOGIES FOR BIOMEDICAL IMAGING AND BIOENGINEERING. THE PROGRAM INCLUDES BIOMATERIALS (BIOMIMETICS, BIOPROCESSING, ORGANOGENESIS, REHABILITATION, TISSUE ENGINEERING, IMPLANT SCIENCE, MATERIAL SCIENCE, INTERFACE SCIENCE, PHYSICS AND STRESS ENGINEERING, TECHNOLOGY ASSESSMENT OF MATERIALS/DEVICES), BIOSENSORS/BIOTRANSDUCERS (TECHNOLOGY DEVELOPMENT, TECHNOLOGY ASSESSMENT, DEVELOPMENT OF ALGORITHMS, TELEMETRY), NANOTECHNOLOGY (NANOSCIENCE, BIOMIMETICS, DRUG DELIVERY SYSTEMS, DRUG BIOAVAILABILITY, MICROARRAY/COMBINATORIAL TECHNOLOGY, GENETIC ENGINEERING, COMPUTER SCIENCE, TECHNOLOGY ASSESSMENT), BIOINFORMATICS (COMPUTER SCIENCE, INFORMATION SCIENCE, MATHEMATICS, BIOMECHANICS, COMPUTATIONAL MODELING AND SIMULATION, REMOTE DIAGNOSIS AND THERAPY), IMAGING DEVICE DEVELOPMENT, BIOMEDICAL IMAGING TECHNOLOGY DEVELOPMENT, IMAGE EXPLOITATION, CONTRAST AGENTS, INFORMATICS AND COMPUTER SCIENCES RELATED TO IMAGING, MOLECULAR AND CELLULAR IMAGING, BIOELECTRICS/BIOMAGNETICS, ORGAN AND WHOLE BODY IMAGING, SCREENING FOR DISEASES AND DISORDERS, AND IMAGING TECHNOLOGY ASSESSMENT AND SURGERY (TECHNIQUE DEVELOPMENT AND TECHNOLOGY DEVELOPMENT).
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Davis,
California
95616
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 259% from $1,453,754 to $5,213,247.
Davis University Of California was awarded
Advanced Biophotonic Technologies Real-Time Medical Decision Making
Project Grant P41EB032840
worth $5,213,247
from the National Institute of Biomedical Imaging and Bioengineering in June 2022 with work to be completed primarily in Davis California United States.
The grant
has a duration of 4 years 9 months and
was awarded through assistance program 93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health.
The Project Grant was awarded through grant opportunity National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional).
Status
(Ongoing)
Last Modified 6/5/25
Period of Performance
6/20/22
Start Date
3/31/27
End Date
Funding Split
$5.2M
Federal Obligation
$0.0
Non-Federal Obligation
$5.2M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for P41EB032840
Transaction History
Modifications to P41EB032840
Additional Detail
Award ID FAIN
P41EB032840
SAI Number
P41EB032840-152299341
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Funding Office
75N800 NIH National Institute of Biomedical Imaging and Bioengineering
Awardee UEI
TX2DAGQPENZ5
Awardee CAGE
1CBG4
Performance District
CA-04
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Health and Human Services (075-0898) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,928,426 | 100% |
Modified: 6/5/25